Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Positive phase III findings for Akten in ocular anesthesia

Jan. 25, 2007

No Comments

E.U. approval for Lucentis in wet AMD

Jan. 24, 2007

No Comments

Enrollment begins in phase III ophthalmic trials of difluprednate

Jan. 24, 2007

No Comments

IND accepted for iCo-007 in diabetic macular edema

Jan. 24, 2007

No Comments

Synergistic effects of triple antiangiogenic therapy in preclinical models of neovascularization

Jan. 23, 2007

No Comments

New therapeutic agents for ocular disorders disclosed in recent patent literature

Jan. 22, 2007

No Comments

Vismed begins phase III study in dry eye syndrome

Jan. 19, 2007

No Comments

Lux receives orphan drug designations for ophthalmic products

Jan. 18, 2007

No Comments

New treatment for macular degeneration reported by Nippon Soda

Jan. 18, 2007

No Comments

U.S. orphan drug designation for LX-211 in uveitis

Jan. 17, 2007

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Ocular
RSS

Positive phase III findings for Akten in ocular anesthesia

E.U. approval for Lucentis in wet AMD

Enrollment begins in phase III ophthalmic trials of difluprednate

IND accepted for iCo-007 in diabetic macular edema

Synergistic effects of triple antiangiogenic therapy in preclinical models of neovascularization

New therapeutic agents for ocular disorders disclosed in recent patent literature

Vismed begins phase III study in dry eye syndrome

Lux receives orphan drug designations for ophthalmic products

New treatment for macular degeneration reported by Nippon Soda

U.S. orphan drug designation for LX-211 in uveitis

Today's news in brief

Today's news in brief

Caplyta star shines as J&J takes Intra-Cellular in $14.6B deal

Abbvie and Simcere enter a $1B T-cell engager deal

Proteomics study explores how protein changes influence disease

Ocular RSS

Ocular
RSS